April 24, 2025
Repositioning approved therapies as nasal sprays
Nasal spray repositioning through the 505(b)(2) regulatory pathway has emerged as a compelling approach, offering a unique opportunity to breathe new life into existing drugs and improve patient experiences.
READ MORE READ MORE